内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Merck & Co., Inc.

MRK · NYSE · CIK 0000310158 · Healthcare · Drug Manufacturers—General

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

55 同一窗口内观察到的 Form 4 交易行
17 sales · 38 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-02-06 · THULIN INGE G · $250.0K

为什么没有活跃信号?

买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Smart Dalton E. IIISVP Fin. - Global Controller
○○○○○○
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
○○▼▼▼▼
Maraldo David R.EVP & Pres. MMD
○○○▼
Larson Betty DEVP, Chief HR Officer
○○○○
Zachary JenniferEVP, General Counsel
○○○▼
Williams David MichaelEVP,Chief Info&Digital Officer
○○○▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后,这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-02-06 · THULIN INGE G.

近期 Form 4 活动

0买入
35卖出
56其他 Form 4 交易行
45SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出17 sale line(s) · 仅供背景
其他38 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
28,271,750
上期报告
34,430,712
日均成交量
11,188,097
回补天数
2.5

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-02-06THULIN INGE G买入 (P)Common Stock2,833USD 88.25USD 250,000SEC 申报 ↗
2025-02-05BAKER DOUGLAS M JR买入 (P)Common Stock15,000USD 88.50USD 1,327,500SEC 申报 ↗
2023-04-26Romanelli Joseph买入 (P)Common Stock3USD 113.68USD 341SEC 申报 ↗
2023-03-20Romanelli Joseph买入 (P)Common Stock136USD 105.47USD 14,344SEC 申报 ↗
2023-02-21Romanelli Joseph买入 (P)Common Stock11USD 109.20USD 1,201SEC 申报 ↗
2022-12-19Romanelli Joseph买入 (P)Common Stock7USD 109.04USD 763SEC 申报 ↗
2022-12-13Romanelli Joseph买入 (P)Common Stock56USD 110.96USD 6,214SEC 申报 ↗
2022-12-06Romanelli Joseph买入 (P)Common Stock30USD 109.39USD 3,282SEC 申报 ↗
2022-12-05Romanelli Joseph买入 (P)Common Stock107USD 109.54USD 11,721SEC 申报 ↗
2022-12-02Romanelli Joseph买入 (P)Common Stock59USD 109.67USD 6,471SEC 申报 ↗

Form 4 申报证据

91 transaction lines in the latest 365-day window; 526 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-13Guindo Chirfi卖出 (S)Common Stock10,000USD 135.00USD 1,350,000SEC 申报 ↗
2026-08-12Zachary Jennifer卖出 (S)Common Stock80,315USD 133.46USD 10,718,840SEC 申报 ↗
2026-08-12Zachary Jennifer期权行权/转换 (M)Common Stock54,927USD 109.78USD 6,029,637SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-13Guindo Chirfi卖出 (S)Common Stock10,000USD 135.00USD 1,350,000SEC 申报 ↗
2026-08-12Zachary Jennifer卖出 (S)Common Stock80,315USD 133.46USD 10,718,840SEC 申报 ↗
2026-08-12Zachary Jennifer期权行权/转换 (M)Common Stock54,927USD 109.78USD 6,029,637SEC 申报 ↗
2026-08-12DeLuca Richard R.卖出 (S)Common Stock11,699USD 131.63USD 1,539,963SEC 申报 ↗
2026-08-11DeLuca Richard R.卖出 (S)Common Stock12,837USD 131.76USD 1,691,419SEC 申报 ↗
2026-08-10DeLuca Richard R.卖出 (S)Common Stock20,784USD 130.43USD 2,710,857SEC 申报 ↗
2026-08-06DeLuca Richard R.卖出 (S)Common Stock6,050USD 130.37USD 788,764SEC 申报 ↗
2026-08-06Guindo Chirfi卖出 (S)Common Stock15,000USD 131.00USD 1,965,000SEC 申报 ↗
2026-08-05Williams David Michael卖出 (S)Common Stock52,847USD 128.77USD 6,805,108SEC 申报 ↗
2026-08-05Williams David Michael期权行权/转换 (M)Common Stock52,847USD 74.49USD 3,936,377SEC 申报 ↗
2026-08-05Maraldo David R.卖出 (S)Common Stock18,706USD 128.72USD 2,407,836SEC 申报 ↗
2026-08-05Maraldo David R.期权行权/转换 (M)Common Stock18,706USD 82.25USD 1,538,495SEC 申报 ↗
2026-05-02Smart Dalton E. III期权行权/转换 (M)Common Stock383USD 112.16USD 42,957SEC 申报 ↗
2026-05-02Smart Dalton E. III代扣税 (F)Common Stock132USD 112.16USD 14,805SEC 申报 ↗
2026-05-02Maraldo David R.期权行权/转换 (M)Common Stock552USD 112.16USD 61,912SEC 申报 ↗
2026-05-02Maraldo David R.代扣税 (F)Common Stock159USD 112.16USD 17,833SEC 申报 ↗
2026-04-30Smart Dalton E. III期权行权/转换 (M)Common Stock464USD 110.95USD 51,481SEC 申报 ↗
2026-04-30Smart Dalton E. III代扣税 (F)Common Stock159USD 110.95USD 17,641SEC 申报 ↗
2026-04-30Larson Betty D期权行权/转换 (M)Common Stock11,350USD 110.95USD 1,259,282SEC 申报 ↗
2026-04-30Larson Betty D代扣税 (F)Common Stock5,143USD 110.95USD 570,616SEC 申报 ↗
2026-04-29Zachary Jennifer期权行权/转换 (M)Common Stock2,951USD 110.03USD 324,699SEC 申报 ↗
2026-04-29Zachary Jennifer代扣税 (F)Common Stock1,454USD 110.03USD 159,984SEC 申报 ↗
2026-04-29Williams David Michael期权行权/转换 (M)Common Stock1,377USD 110.03USD 151,511SEC 申报 ↗
2026-04-29Williams David Michael代扣税 (F)Common Stock679USD 110.03USD 74,710SEC 申报 ↗
2026-04-29Smart Dalton E. III期权行权/转换 (M)Common Stock944USD 110.03USD 103,868SEC 申报 ↗
2026-04-29Smart Dalton E. III代扣税 (F)Common Stock324USD 110.03USD 35,650SEC 申报 ↗
2026-04-29Oosthuizen Johannes Jacobus期权行权/转换 (M)Common Stock1,377USD 110.03USD 151,511SEC 申报 ↗
2026-04-29Oosthuizen Johannes Jacobus代扣税 (F)Common Stock679USD 110.03USD 74,710SEC 申报 ↗
2026-04-29Litchfield Caroline期权行权/转换 (M)Common Stock3,935USD 110.03USD 432,968SEC 申报 ↗
2026-04-29Litchfield Caroline代扣税 (F)Common Stock1,938USD 110.03USD 213,238SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码MRK
CIK0000310158
行业Healthcare
细分行业Drug Manufacturers—General Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所NYSE

数据覆盖

本地 Form 4 历史526 transaction lines from 2020-01-13 to 2026-08-13
10 P purchase lines · 130 S sale lines · 386 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.